Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Brand

Showing results (1-10 of 163) with videos related to

Pageof 17
Sort By:
The American Journal of Gastroenterology|September 6, 2013
Response to Tsai et alStephan Brand
MMW Fortschritte Der Medizin|March 7, 2015
[Medical therapy of ulcerative colitis]Stephan Brand
Gut|February 1, 2013
Moving the genetics of inflammatory bowel diseases from bench to bedside: first steps towards personalised medicineStephan Brand
Inflammatory Bowel Diseases|November 1, 2011
Homozygosity for the NOD2 p.Leu1007fsX1008 variant is the main genetic predictor for fibrostenotic Crohn's diseaseStephan Brand
Inflammatory Bowel Diseases|August 1, 2008
IL-22: a two-headed cytokine in IBD?Julia Seiderer, Stephan Brand
Alimentary Pharmacology & Therapeutics|November 19, 2024
Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' ReplySimon Woelfel, Stephan Brand
Alimentary Pharmacology & Therapeutics|January 9, 2025
Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative ColitisSimon Woelfel, Stephan Brand
Gut|May 13, 2011
PSC: Protect and serve with colitis: does it help the liver to have severe ulcerative colitis?Christian Rust, Stephan Brand
Wirtschaftsdienst (Hamburg, Germany : 1949)|January 25, 2021
[Municipal Finance in the Corona Crisis - Cuts, but not a Turnaround]Stephan Brand, Johannes Steinbrecher
Frontiers in Immunology|October 11, 2023
Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cellsJulia Diegelmann, Stephan Brand
Pageof 17

Showing results (1-10 of 163) with videos related to

Sort By:
Pageof 17
The American Journal of Gastroenterology|September 6, 2013
Response to Tsai et alStephan Brand
MMW Fortschritte Der Medizin|March 7, 2015
[Medical therapy of ulcerative colitis]Stephan Brand
Gut|February 1, 2013
Moving the genetics of inflammatory bowel diseases from bench to bedside: first steps towards personalised medicineStephan Brand
Inflammatory Bowel Diseases|November 1, 2011
Homozygosity for the NOD2 p.Leu1007fsX1008 variant is the main genetic predictor for fibrostenotic Crohn's diseaseStephan Brand
Inflammatory Bowel Diseases|August 1, 2008
IL-22: a two-headed cytokine in IBD?Julia Seiderer, Stephan Brand
Alimentary Pharmacology & Therapeutics|November 19, 2024
Editorial: Updated COVID-19 Boosters-Tailoring Protection for Patients With IBD. Authors' ReplySimon Woelfel, Stephan Brand
Alimentary Pharmacology & Therapeutics|January 9, 2025
Editorial: Individualising JAK Inhibitor Selection for Patients With Ulcerative ColitisSimon Woelfel, Stephan Brand
Gut|May 13, 2011
PSC: Protect and serve with colitis: does it help the liver to have severe ulcerative colitis?Christian Rust, Stephan Brand
Wirtschaftsdienst (Hamburg, Germany : 1949)|January 25, 2021
[Municipal Finance in the Corona Crisis - Cuts, but not a Turnaround]Stephan Brand, Johannes Steinbrecher
Frontiers in Immunology|October 11, 2023
Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cellsJulia Diegelmann, Stephan Brand
Pageof 17